30 jul: Råvarer: Økonomisk stimuli sender prisen på råvarer i vejret
30 jul: Obligationer/åbning: Spanske renter fortsætter ned
30-07-2012 08:45:00

Reckitt Benckiser Warns on Mature Markets as Profit Rises

Relateret indhold

By Simon Zekaria

LONDON--Reckitt Benckiser PLC (RB.LN) Monday warned on a tough outlook for consumer spending in mature markets as it posted a slight rise in profit, helped by demand for household and medical products in emerging markets.

"While the consumer and competitive environment in Europe and North America remains challenging, we are doing the right things for the long term," said Chief Executive Rakesh Kapoor.

The U.K.-based maker of Air Wick air freshener, Dettol disinfectant and Neurofen pain relief tablets said net profit in the six months to June 30 rose 2.6% to GBP779 million ($1.22 billion) from GBP759 million a year earlier. Revenue in the period rose to GBP4.67 billion from GBP4.62 billion.

Second-quarter revenue fell 1.1% to GBP2.31 billion from GBP2.34 billion, missing market expectations from a company poll of GBP2.35 billion. However, like-for-like revenue rose 4%.

Unilever NV (UN) last week warned consumer companies are operating in a deteriorating global economy as it reported a small drop in net profit, while U.S.-based market leader Procter & Gamble Co. (PG) has issued two profit warnings this year, blaming weak demand in mature markets where spending is squeezed.

Rising middle-class populations with increased spending power in countries like Brazil, India and Indonesia are driving demand for high-margin health and hygiene goods. In contrast, Western economies, particularly in Europe, are seeing a cutback in consumer purchases amid weak economic conditions.

Earlier this year, Reckitt announced plans to merge its North American and European operations in a bid to focus investment and resources in emerging markets. Its goal is to generate half of its sales in developing economies, excluding food and pharmaceuticals, by 2016, up from just over 40% currently.

The move is aimed at reversing a recent slowdown in business. Last year saw the departure of CEO Bart Becht, the man credited with delivering consistent profit growth and more than quadrupling the company's share price since taking over in 1999. His replacement, Mr. Kapoor, is now tasked with guiding the company through an increasingly turbulent market.

Slough, England-based Reckitt Benckiser, which makes products as diverse as French's yellow mustard and Suboxone, a heroin addiction treatment, is aiming for comparable full-year revenue, excluding its pharmaceutical operations, to exceed forecast market growth of 1% to 2% by two percentage points, and to sustain this trajectory in the medium term. Excluding pharmaceuticals, it aims to maintain its operating margins.

It recommended an interim dividend of 56 pence a share, up 2% year-on-year.

Reckitt Benckiser shares closed Friday at 3542 pence, valuing the company at GBP25.61 billion, up 11% in the year to date.

Write to Simon Zekaria at simon.zekaria@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 30, 2012 02:45 ET (06:45 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo: EMA-udvalg anbefaler markedsføringstilladelse til Refixia - NY

24-03-2017 13:31:36
Udvalget for humanmedicinske lægemidler (CHMP) ved Det Europæiske Lægemiddelsagentur (EMA) har tildelt Novo Nordisks Refixia en positiv udtalelse og anbefaler en markedsføringstilladelse.Det skriver Novo Nordisk i en fondsbørsmeddelelse.CHMP anbefaler en markedsføringstilladelse til Refixia til unge og voksne med hæmofili B. Til grund for anbefalingen ligger resultater fra udviklingsprogrammet par..

Novo/Exane: Kursmålet skæres til 270 kr.

24-03-2017 10:17:22
Den franske storbank Exane BNP Paribas skærer kursmålet for aktien i Novo Nordisk til 270 kr. fra 295 kr. Anbefalingen er uændret "outperform", viser data fra Bloomberg.Novo-aktien falder fredag 0,4 pct., eller 1 kr., til 233,20 kr. Det dækker dog over en stigning, da aktien ikke længere handles inklusive retten til et udbytte på 4,60 kr./ritzau/FINANSJakob Dalskov +45 33 30 03 35 Ritzau Finans, E..

Aktier/tendens: Mulighed for mere gas til Mærsk i ventet rødt C20

24-03-2017 08:31:54
Det danske aktiemarked kan fredag blive præget af små udsving med en lille overvægt af negative fortegn.A.P. Møller-Mærsks B-aktie var uændret efter torsdagens handel og blev handlet til 11.500 kr. Aktien kan dog gå fra grå til grøn fredag, da der er potentielt gode nyheder til det danske konglomerat.Efter en Nordsø-aftale, der kan redde det ellers lukningstruede Tyra-felt, skriver Jyllands-Posten..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Procter & Gamble Company.. 90,57 -0,2% Fald i aktiekurs
Unilever NV 50,26 0,4% Stigning i aktiekurs
Unilever PLC 50,17 0,3% Stigning i aktiekurs
Unilever PLC ORD 3 1/9P 4.035,00 0,4% Stigning i aktiekurs
Reckitt Benckiser Group .. 7.344,34 0,0% Fald i aktiekurs
Unilever DR 46,60 0,0% Aktiekurs uændret
Procter Gamble 83,00 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. marts 2017 04:39:36
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170324.2 - EUROWEB4 - 2017-03-27 04:39:36 - 2017-03-27 04:39:36 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x